Showing results (3501-3510 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|June 6, 2015
Atypical antipsychotics and inverse agonism at 5-HT2 receptorsLaura C Sullivan, William P Clarke, Kelly A BergCurrent Pharmaceutical Design|June 6, 2015
Treatment of Cognitive Impairment in Schizophrenia: Potential Value of Phosphodiesterase Inhibitors in Prefrontal DysfunctionMarlies Van Duinen, Olga A H Reneerkens, Lena Lambrecht, et al.Current Pharmaceutical Design|June 6, 2015
Neuropeptide Receptor Ligands for the Treatment of Schizophrenia: Focus on Neurotensin and TachykininsGuy GriebelCurrent Pharmaceutical Design|June 6, 2015
When is a Proof-of-Concept (POC) not a POC? Pomaglumetad (LY2140023) as a Case Study for Antipsychotic EfficacyGerard J MarekCurrent Pharmaceutical Design|August 13, 2016
Adolescent Cannabis Use: What is the Evidence for Functional Brain Alteration?Valentina Lorenzetti, Silvia Alonso-Lana, George J Youssef, et al.Current Pharmaceutical Design|August 13, 2016
Importance of ABC Transporters in Drug DevelopmentMarcel Benadiba, Yehoshua MaorCurrent Pharmaceutical Design|June 2, 2015
EHDA Spraying: A Multi-Material Nano-Engineering RouteRita Haj-Ahmad, Manoochehr Rasekh, Kazem Nazari, et al.Current Pharmaceutical Design|June 2, 2015
Formulation and Stability Aspects of Nanosized Solid Drug Delivery SystemsPeter Szabo, Romana ZelkoCurrent Pharmaceutical Design|July 14, 2015
The Function and Regulation of BMP6 in Various Kinds of Stem CellsRuinan Shen, Ruobing Jia, Wenjie Liu, et al.Current Pharmaceutical Design|July 29, 2016
Solving the Blood-Brain Barrier Challenge for the Effective Treatment of HIV Replication in the Central Nervous SystemLuc Bertrand, Madhavan Nair, Michal ToborekPageof 1,008